GRDN Guardian Pharmacy Services, Inc. Class A Common Stock

NYSE · US · Healthcare · Medical Care Facilities · guardianpharmacy.com

42.38USD+3.77%Mkt Cap: 2.68B $P/E: 40.753d ago

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualiz…

Industry Peers

Medical Care Facilities

Screen all

HCA

HCA Healthcare, Inc. Common Stock

$94.66BUSDP/E 14.3

FRE

Fresenius SE & Co. KGaA

$26.71BUSDP/E 15.8

THC

Tenet Healthcare Corporation Common Stock

$20.82BUSDP/E 10.0

FME

Fresenius Medical Care AG & Co. KGaA

$11.55BUSDP/E 11.9

FMS

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

$11.84BUSDP/E 11.8

EHC

Encompass Health Corporation Common Stock

$11.82BUSDP/E 20.0

DVA

DaVita Inc. Common Stock

$11.47BUSDP/E 15.1

UHS

Universal Health Services, Inc. Common Stock

$10.36BUSDP/E 7.2

ENSG

The Ensign Group, Inc. - Common Stock

$10.01BUSDP/E 26.9

PACS

PACS Group, Inc. Common Stock

Concentra Group Holdings Parent, Inc. Common Stock

$4.55BUSDP/E 23.0

LFST

LifeStance Health Group, Inc. - Common Stock

National HealthCare Corporation Common Stock

$3.57BUSDP/E 25.6

OPCH

Option Care Health, Inc. - Common Stock

$3.39BUSDP/E 17.2

AVAH

Aveanna Healthcare Holdings Inc. - Common Stock

$2.75BUSDP/E 10.0

ACHC

Acadia Healthcare Company, Inc. - Common Stock

$2.61BUSD

BKD

Brookdale Senior Living Inc. Common Stock

$2.59BUSD

Pediatrix Medical Group, Inc. Common Stock

$2.11BUSDP/E 12.4

Key Statistics

Company

Market Cap2.68B USD

Enterprise Value2.55B USD

Revenue (TTM)1.46B USD

Gross Profit292.72M USD

Net Income (TTM)49.22M USD

Revenue/Share23.22 USD

Last Price42.38 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees3.6K

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)40.75

P/E (Forward)28.47

PEG—

EV/EBITDA23.29

EV/Revenue1.74

P/S1.77

P/B10.53

EPS (TTM)1.04

EPS (Forward)1.43

52W Range

23.1477% of range48.26

52W High48.26 USD

52W Low23.14 USD

Profitability

Gross Margin20.21%

Oper. Margin3.48%

EBITDA Margin7.48%

Profit Margin3.40%

ROE23.92%

ROA11.93%

Growth

Revenue Growth2.20%

Earnings Growth139.80%

Cash Flow & Leverage

Operating CF100.25M USD

CapEx (TTM)19.55M USD

FCF Margin4.41%

FCF Yield2.40%

Net Debt-50.54M USD

Net Debt/EBITDA-0.46

Balance Sheet

Debt/Equity0.18

Current Ratio1.65

Quick Ratio1.26

Book Value/Sh3.88 USD

Cash/Share1.42 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.1 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)49.86 USD

Upside (mean)+17.6%

Target Range47.00 USD – 52.00 USD

47.00+17.6% to mean52.00

# Analysts7

Ownership

Shares Out.63.32M

Float32.01M

Insiders57.45%

Institutions60.67%

Short Interest

Short Ratio5.1d

Short % Float6.54%

Short % Out.3.83%

Shares Short2.43M

Short (prev mo.)3.01M

Technical

SMA 5040.81 (+3.9%)

SMA 20037.02 (+14.5%)

Beta0.06

S&P 52W Chg13.94%

Avg Vol (30d)612.46K

Avg Vol (10d)808.25K

Technical Indicators

RSI (14)52.3

MACD0.1394

MACD Signal0.5868

MACD Hist.-0.4474

BB Upper47.68 USD

BB Middle43.28 USD

BB Lower38.88 USD

BB Width20.34%

ATR (14)1.668 USD

Vol Ratio (20d)0.73x